Clinical Trials in Salt Lake City

Showing 7981-8000 of 12,670 trials

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

NCT02014441

The primary objective was to estimate the proportion of participants with detectable talimogene laherparepvec deoxyribonucleic acid (DNA) in the blood and urine at any time after administration of talimogene laherparepvec within the first 3 cycles.

Melanoma

Amgen61 participantsStarted Apr 2014

Tampa, Florida, United States • Indianapolis, Indiana, United States • Louisville, Kentucky, United States +11 more locations

TERMINATEDPhase 2< 1 mile

A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

NCT01203943

The primary purpose of the study is to evaluate the safety and PK profile of CC-930 in idiopathic pulmonary fibrosis patients.

Idiopathic Pulmonary FibrosisPulmonary FibrosisFibrosis+2 more

Celgene28 participantsStarted Jan 2011

Birmingham, Alabama, United States • Sacramento, California, United States • Stanford, California, United States +19 more locations

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

Find Trials by Condition in Salt Lake City

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Study of Debio 1450 for Bacterial Skin Infections

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

POSITIVE Stroke Clinical Trial

Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease